D) We will limit the use of dexamethasone to one dose (40mg) just before the administration of rituximab based on in vitro data. In contrast to multiple myeloma, there is no evidence that dexamethasone is essential for the treatment of WM. Furthermore repetitive administration of dexamethasone may be associated with increased risk for opportunistic infections.